Regaining compliance with Nasdaq's minimum bid price requirement is a significant positive development for 180 Life Sciences Corp. It removes the immediate risk of delisting, which can be a major concern for investors and can negatively impact stock price and liquidity. This news is likely to be viewed positively by the market, potentially leading to increased investor confidence and support for the stock price in the short term.